Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
TYK Medicines, Inc
OncoResponse, Inc.
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Fujian Medical University
QureBio Ltd.
Kineta Inc.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Shandong Cancer Hospital and Institute
Mansoura University
National University Hospital, Singapore
National University Hospital, Singapore
Glycostem Therapeutics BV
Taiga Biotechnologies, Inc.
Scandion Oncology A/S
Waterford Instituate of Technology
Beijing Immunochina Medical Science & Technology Co., Ltd.
Accendatech USA Inc.
Royal Marsden NHS Foundation Trust
ImmunoVaccine Technologies, Inc. (IMV Inc.)
University Hospital Tuebingen
Butantan Institute
Vietlife Healthcare Corporation
Hamlet Pharma AB
Shenzhen Geno-Immune Medical Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Acibadem University
Sichuan Cancer Hospital and Research Institute
Shenzhen Geno-Immune Medical Institute
Radboud University Medical Center
Asclepius Technology Company Group (Suzhou) Co., Ltd.
Clinica Universidad de Navarra, Universidad de Navarra
Shenzhen Geno-Immune Medical Institute
Hadassah Medical Organization
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Zhejiang University
East and North Hertfordshire NHS Trust
LondonPharma Ltd.
Hanmi Pharmaceutical Company Limited
Jichi Medical University
Karolinska University Hospital
Alaunos Therapeutics
Instituto de Investigação em Imunologia
Visualase, Inc.
Pepscan Therapeutics
Tokyo University
Providence Health & Services
Minimal Access Therapy Training Unit
Callisto Pharmaceuticals
Aronex Pharmaceuticals